Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05814536
Status:
TERMINATED
Last Update Posted:
2023-12-14
First Post:
2023-03-20
Brief Title:
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
Sponsor:
AnHeart Therapeutics Inc
Organization:
AnHeart Therapeutics Inc
Organization Data
Organization:
AnHeart Therapeutics Inc
Class:
INDUSTRY
Study ID:
AB-218-G104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AnHeart Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None